IP Verse

Oligomeric Compounds And Compositions For Use In Modulation Of Small Non-Coding Rnas

Patent No. EP2530157 (titled "Oligomeric Compounds And Compositions For Use In Modulation Of Small Non-Coding Rnas") was filed by Regulus Therapeutics on Jul 30, 2004. The application was issued on Sep 28, 2016.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
HABERMANNJun 28, 2017HABERMANN
ROCHE INNOVATION CENTER COPENHAGEN A/SJun 26, 2017D YOUNG

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2530157

REGULUS THERAPEUTICS
Application Number
EP12173039A
Filing Date
Jul 30, 2004
Status
Revoked
Jun 28, 2019
Publication Date
Sep 28, 2016
External Links
Slate, Register , Google Patents